Company · CIK 0001390478 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
SELLAS Life Sciences Group, Inc. · SLS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 AForm 4 → | Jun 18, 4:30 pm EDT | Angelos M. StergiouPresident and CEO, Director | 1,065,000 | — | — | 1,759,183 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.